Market Tracker

02/27 10:16am ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

11.60
BATS BZX Real-Time Price
As of 10:16am ET
 -0.33 / -2.77%
Today’s Change
10.85
Today|||52-Week Range
18.48
-18.02%
Year-to-Date

Today’s Trading

Previous close11.93
Today’s open11.93
Day’s range11.75 - 12.17
Volume301,110
Average volume (3 months)1,585,110
Market cap$1.2B
Dividend yield--
Data as of 10:01am ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-63.84%
Earnings growth (this year)-98.90%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales149.87
Price/Book21.72

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo BioSciences ...-0.53-3.12%
NXTMNxStage Medical Inc-0.54-2.98%
BRLIBio-Reference Labora...-0.18-0.51%
ARIAARIAD Pharmaceutical...+0.15+1.84%
Data as of 10:16am ET, 02/27/2015

Financials

Last reporting dateFebruary 27, 2015
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$7.0M
Annual profit (last year)-$46.7M
Net profit margin-667.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ronald Bentsur
President, Chief Operating Officer &
Executive VP
Gregory P. Madison
Corporate headquarters
New York, New York

Forecasts